Erschienen in:
01.04.2009 | CLINICAL CORRESPONDENCE
Pioglitazone-induced heart failure in a patient with restrictive cardiomyopathy and metabolic myopathy
verfasst von:
Univ. Prof. DDr. Josef Finsterer, MD, PhD, Claudia Stöllberger, MD
Erschienen in:
Clinical Research in Cardiology
|
Ausgabe 4/2009
Einloggen, um Zugang zu erhalten
Excerpt
Sirs: Restrictive cardiomyopathy (rCMP) is echocardiographically characterized by bilaterally enlarged atria, a restrictive filling pattern (deceleration time <150 ms) but normal systolic function [
20]. Although rCMP has been repeatedly reported as a cardiac manifestation of various neuromuscular disorders (NMDs), the association of pioglitazone-induced heart failure in a patient with rCMP due to a metabolic myopathy has not been reported. …